PHARMACEUTICAL EXECUTIVE NEWSLETTER

In this ISSUE

Patient Groups Challenged on Pharma Ties

The Doctor is Not In: A Test & Learn Approach to Enhancing the Impact of Non-Personal Promotion

Experts Propose Licensing Deal to Expand Access to Hep C Therapies

Executive Profile

HBA's Woman of the Year 2017

For Bahija Jallal, this year's Healthcare Businesswomen’s Association Woman of the Year, a passion for translational science has been the central guide in a career rise from cancer researcher to leading a big pharma biotech engine.
... /Read more/

2017 Real-World Evidence Benchmark Survey
Deloitte’s 2017 Real-World Evidence Benchmark Survey shows that life sciences companies are making some progress in using RWE but still have opportunities to expand applications across the value chain, consider new channels to access RWD, and improve their overall capabilities.

Explore this research Today!

Regulatory Affairs

FDA in Debate over Developing, Pricing New Cancer Therapies

Amidst hundreds of presentations on new developments in cancer research and treatment discovery at the AACR meeting last week, FDA policies for speeding promising new therapies to patients garnered a good deal of attention.
... /Read more/

Winning the RAT race: A new Center of Excellence to drive development of regenerative medicines
Live Webinar: Tuesday, May 2 at 11:00am EDT

Regulatory Affairs

Compliance Regulations for Life Sciences Companies in the Trump Era

We know deregulation is coming, although we do not know what it will look like. The one looming question for pharmaceutical and medical device companies is about the future of compliance and regulations.
... /Read more/

Opinion

Pharma’s Understanding of Competitive Intelligence

Despite the investment in place, industry still struggles to take advantage of competitive intelligence as a key decision aid.
... /Read more/

Regulatory Affairs

A Faster, More Flexible, and Frugal FDA?

Jill Wechsler outlines how the new FDA commissioner tasked with curbing regulation, speeding approvals—and collecting more fees to do it.
... /Read more/

Calendar

/ Formulary, Co-Pay and Access Summit 4/11-4/12 /

/ Next Generation Pharmaceutical Samples 4/12-4/13 /

/ Specialty Pharma Association 2017 Annual Pharma Conference 4/26-4/28 /

/ PCC 2017 – CBI’s 14th Annual Pharmaceutical Compliance Congress 4/26-4/28 /

update my profile / advertise with us / print & digital subscribe / visit pharmexec.com